Insider · CIK 0001599014
David Roth
Files at SYRS (Syros Pharmaceuticals, Inc.). First filing Nov 20, 2024, latest Nov 20, 2024.
In brief
David Roth files SEC Form 4 as officer at SYRS (Syros Pharmaceuticals, Inc.). Since Nov 20, 2024, David Roth has reported 0 open-market buys worth $0 and 1 open-market sell worth $2,382, the latest filed on Nov 20, 2024.
A track record needs three past buys with six months of prices behind them; David Roth has 0, so none is measured yet.
The newest scored trade: sold $2,382 of SYRS on Nov 18, 2024, filed Nov 20, 2024, scored 50 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SYRS: Syros Pharmaceuticals, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 50Moderate | Syros Pharmaceuticals, Inc. | $2,382 12,099 shares | -100% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Nov 18, 2024 | SYRS Syros Pharmaceuticals, Inc. | 12,099 0.05% of outstanding | $2,382 | Nov 18, 2024 | $14k |
| Dec 12, 2023 | SYRS Syros Pharmaceuticals, Inc. | 6,287 0.03% of outstanding | $31k | Dec 12, 2023 | $25k |
| Dec 6, 2023 | SYRS Syros Pharmaceuticals, Inc. | 6,287 0.03% of outstanding | $25k | Dec 6, 2023 | none |
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 18, 2024 | SYRS Syros Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -12,099 | $0.20 | $2,382 | 0 | Nov 20, 2024 |
| Oct 31, 2024 | SYRS Syros Pharmaceuticals, Inc. | MOption exercise Common Stock10b5-1 | +18,875 | - | - | 18,875 | Nov 4, 2024 |
| Oct 31, 2024 | SYRS Syros Pharmaceuticals, Inc. | FTax withholding Common Stock10b5-1 | -6,776 | $2.09 | $14k | 12,099 | Nov 4, 2024 |
| Oct 31, 2024 | SYRS Syros Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative10b5-1 | -18,875 | $0.00 | $0 | 0 | Nov 4, 2024 |
Questions about David Roth
Answered from the filings on this page, as of the latest one.
Is David Roth buying or selling?
Not in the last 12 months. David Roth's latest open-market trade on SEC Form 4 was sold $2,382 of SYRS on Nov 18, 2024.
How did David Roth's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David Roth has 0.
Where does David Roth file Form 4?
David Roth has filed Form 4 at SYRS (Syros Pharmaceuticals, Inc.) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.